Researchers Find SARS-CoV-2 Inhibitors : vimarsana.com

© V. Namasivayam/Pharmazeutisches Institut/Uni Bonn
A research team of pharmacists at the University of Bonn has discovered two families of active substances that can block the replication of the SARS-CoV-2 coronavirus. The drug candidates are able to switch off the the key enzyme of the virus, the so-called main protease. The study is based on laboratory experiments. Extensive clinical trials are still required for their further development as therapeutic drugs. The results have now been published in the journal
In order for the SARS-CoV-2 coronavirus to replicate, it relies on the main protease as a key enzyme. The virus first has its genome translated from RNA into a large protein strand. The viral main protease then cuts this protein chain into smaller pieces, from which the new virus particles are formed. "The main protease is an extremely promising starting point for coronavirus drug research," says professor Dr. Christa E. Müller of the Pharmaceutical Institute at the University of Bonn. "If this enzyme is blocked, viral replication in the body's cells is stopped." The researcher is a member of the Transdisciplinary Research Area "Life and Health" at the University of Bonn.

Related Keywords

Bonn , Nordrhein Westfalen , Germany , Vigneshwaran Namasivayam , Maria Zyulina , Phuong Vu , V Namasivayam Pharmazeutisches Institut , Julian Breidenbach , Miriam Diett , Katharina Sylvester , Ghazl Al Hamwi , Carina Lemke , Angewandte Chemie , University Of Bonn , Institute Of The University Bonn , Transdisciplinary Research Area Life , Researchers Find , Pharmaceutical Institute , Transdisciplinary Research Area , Laura Sch , Uni Bonn , பொன் , னோற்ர்ேன் வெஸ்ட்ஃபாலன் , ஜெர்மனி , புோங்க் உ , ஜூலியன் ப்ரீடன்பாக் , காதரின சில்வெஸ்டர் , கரினா லெம்கீ , பல்கலைக்கழகம் ஆஃப் பொன் , நிறுவனம் ஆஃப் தி பல்கலைக்கழகம் பொன் , ஆராய்ச்சியாளர்கள் கண்டுபிடி , மருந்து நிறுவனம் , லாரா ஸ்ச் , யூனி பொன் ,